References
- Ali M, McDonald J WD, Thiessen J J, Coates P E. Plasma acetylsalicylate and salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin. Stroke 1980; 11: 9–13
- Bjornsson T D, Scheider D E, Berger H. Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels. J Pharm Exp Ther 1989; 250: 154–161
- Buchanan M R, Hirsh J. Effect of aspirin on hemostasis and thrombosis. NER Allergy Proc 1986; 7: 26–31
- Burch J W, Stanfold N, Majerus P W. Inhibition of platelet prostaglandin synthetase by oral aspirin. J Clin Invest 1978; 61: 314–319
- Cerletti C, Gambino M C, Bucchi F, Rajtar G, Riva E, de Gaetano G. Comparison of the effects of oral and intravenous aspirin administration on platelet and peripheral vascular cyclo-oxygenase activity: studies in rats and in man. Proc 3rd Cologne Atherosclerosis Con, Agents and Actions 1986; 20: 239–248
- De Caterina R, Giannessi D, Gazzetti P, Bernini W. Inhibition of platelet aggregation and thromboxane B2 production during aspirin treatment. Dependence on the dose of the aggregating agent. Thromb Res 1985; 37: 337–342
- Kitchingman G K, Prichard P J, Daneshmend T K, Walt R P, Hawkey C J. Enhanced gastric mucosal bleeding with doses of aspirin used for prophylaxis and its reduction by ranitidine. Br J Clin Pharm 1989; 28: 581–585
- Lewis H D, David J W, Archibald D G. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. N Engl J Med 1983; 309: 396–493
- Lorenz R L, Weber M, Kotzur J. Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily): effects on platelet aggregation and thromboxane formation. Lancet 1984; 9: 1261–1264
- Majerus P W. Arachidonate metabolism in vascular disorders. J Clin Invest 1983; 72: 1521–1525
- Mitchell G M, Frykman G K, Morrison W A, O'Brien BMcC. The nature and extent of histopathologic injury in human avulsed arteries and veins and in experimentally avulsed monkey arteries. Plast Reconstr Surg 1986; 78: 801–810
- Moncada S, Vane J R. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane-A2 and prostacyclin. Pharmacol Rev 1978; 30: 293–331
- Naschitz J E, Yeshurun D, Odeh M. Overt gastrointestinal bleeding in the course of chronic low-dose aspirin administration for secondary prevention of arterial occlusive disease. Am J Gastr 1990; 85: 408–411
- Nilsson I M, Olow B. Fibrinolysis induced by streptokinase in man. Acta Chir Scand 1962; 123: 247–266
- Packham M A, Mustard F J. Pharmacology of platelet-affecting drugs. Circulation 1980; 62: 26–41, Suppl V
- Pedersen A K, Fitzgerald G A. Dose-related kinetics of aspirin: presystemic acetylation of platelet cyclo-oxygenase. N Engl J Med 1984; 311: 1206–1211
- Phsyicians Health Study Research Group. Preliminary report: findings from the aspirin component of the ongoing physicians' health study. N Engl J Med 1988; 318: 262–265
- Salemark L. An international survey of current microvascular practices in free tissue transfer and replantation surgery. Microsurgery 1991; 12: 308–311
- Salemark L, Wieslander J B, Dougan P, Arnljots B. Time of low-dose acetylasalicylic acid administration influences in vivo platelet function and thrombus formation following arteriotomy and intimectomy; an experimental study in small arteries of rabbits. Microsurgery 1990; 11: 209–214
- Salemark L, Wieslander J B, Dougan P. Does acetylsalicylic acid improve patency following severe trauma in small arteries?, Submitted for publication
- Sinzinger H, O'Grady J, Fitscha P, Kaliman J. Extremely low-dose aspirin (one milligram per day) renders human platelets more sensitive to antiaggregation prostaglandins. N Engl J Med 1984; 311: 1052
- UK-TIA Study Group. The UK-TIK aspirin trial: interim results. Br Med J 1988; 296: 316
- Vesterqvist O. Rapid recovery of in vivo prostacyclin formation after inhibition by aspirin. Eur J Clin Pharmacol 1986; 30: 69–73
- Wieslander J B, Dougan P. Low dose ASA (4 mg/kg) peroperatively does not prevent in vivo platelet accumulation at microarterial anastomotic sites. An experimental study in the rabbit. Scand J Plast Reconstr Hand Surg 1990; 24: 21–26